Inflammation & Allergy - Drug Targets (Discontinued)
Title: Editorial
Volume: 6 Issue: 1
Author(s): James L. Ellis
Affiliation:
Export Options
About this article
Cite this article as:
Ellis L. James, Editorial, Inflammation & Allergy - Drug Targets (Discontinued) 2007; 6 (1) . https://dx.doi.org/10.2174/187152807780077336
DOI https://dx.doi.org/10.2174/187152807780077336 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
8
Related Articles
-
Selective Cyclooxygenase Inhibitors: Current Status
Current Drug Discovery Technologies Pharmacogenomics – Implications in the Development of HIV-Associated Brain Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Meet Our Associate Editorial Board Member
Recent Patents on Anti-Cancer Drug Discovery Evaluation of Osteoporosis Risk Associated with Chronic Use of Morphine, Fentanyl and Tramadol in Adult Female Rats
Current Drug Safety The Gut Microbiome and Alzheimer’s Disease: A Growing Relationship
Current Alzheimer Research Walking the Oxidative Stress Tightrope: A Perspective from the Naked Mole-Rat, the Longest-Living Rodent
Current Pharmaceutical Design Biomarkers of Oxidative Stress in the Assessment of Enantioselective Toxicity of Chiral Pesticides
Current Protein & Peptide Science The Effects of Psychological Stress on Depression
Current Neuropharmacology Pharmacological Interference with Transcriptional Control of Osteoblasts A Possible Role for Leptin and Fatty Acids in Maintaining Bone Strength and Body Lean Mass
Current Pharmaceutical Design Novel Drug Delivery System for Cancer Management: A Review
Current Cancer Therapy Reviews ETS Proteins and MMPs: Partners in Invasion and Metastasis
Current Drug Targets Screening for Liver Disease - are LFTs Old HAT?
Current Medicinal Chemistry Fat Digestion and its Role in Appetite Regulation and Energy Balance -The Importance of Enterostatin and Tetrahydrolipstatin
Current Medicinal Chemistry - Central Nervous System Agents The Synergistic Use of Computation, Chemistry and Biology to Discover Novel Peptide-Based Drugs: The Time is Right
Current Pharmaceutical Design Lifestyle Factors and Endothelial Function
Current Vascular Pharmacology Targeting Different Signaling Pathways with Antisense Oligonucleotides Combination for Cancer Therapy
Current Pharmaceutical Design Design of Combretastatin A-4 Analogs as Tubulin Targeted Vascular Disrupting Agent with Special Emphasis on Their Cis-Restricted Isomers
Current Pharmaceutical Design The Role of Oxidative Stress in the Pathogenesis of Type 2 Diabetes Mellitus Micro- and Macrovascular Complications: Avenues for a Mechanistic-Based Therapeutic Approach
Current Diabetes Reviews Cytokines Polymorphism and mRNA Expression as Biomarkers in HCV Treatment Response
Recent Patents on Biomarkers Vascular Dysfunction in Aging: Potential Effects of Resveratrol, an Anti- Inflammatory Phytoestrogen
Current Medicinal Chemistry